Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas.
about
Targeting pediatric cancer stem cells with oncolytic virotherapyNew therapeutic targets in soft tissue sarcoma.Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives.Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.Targeting cancer stem cells with oncolytic virusAblation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas.Progress of oncolytic viruses in sarcomas.Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.The role of telomeres in musculoskeletal diseases.Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress.The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity.Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells.A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus.Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.Detection of circulating tumor cells in cervical cancer using a conditionally replicative adenovirus targeting telomerase-positive cells.Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis.
P2860
Q34262327-3E3F338D-3924-4B3D-8045-5F1C352B44D0Q34267924-DC21ACB9-D516-4DFB-857E-85C45E58CE54Q34415371-5FC8300B-5421-40D4-B655-9C68695701B0Q35153125-AF7B94C5-75EC-47F6-9DE7-EC8E5D9E2E93Q36756809-E834D719-D2BD-4E90-B748-D48E3E8950F1Q37044088-D2829D2A-02F9-4F97-81BD-4485B246A706Q37054272-0639E909-5C1F-4EB9-A3CA-1CF2EC659449Q37982449-E29B14C8-6FEE-419E-AE63-E3B4E9F4DC36Q38025696-AEE88B82-D14D-46F9-BB3C-878807598F56Q38042771-F73FB6D9-F25A-4C50-936A-37A174106927Q38866745-2525EFCC-E6D3-4288-AF14-384CD5AFADA5Q39003657-3ADDD63B-032A-477F-9338-B11C8C3C6239Q39020219-776AB43A-53EE-44F8-908C-159470C88507Q39099804-00950880-D9D7-4026-B827-46871146836BQ39413029-C38EF05A-17ED-46F5-B180-6F1D615BDFDAQ40177986-534EFB28-AC13-4794-B54A-B73533486341Q41595578-D57D2D86-CE09-4B3C-83D9-FEB318BBCA49Q47576014-B83626B0-42B2-4511-987C-F51BE759542CQ54315299-8A9C83BC-A273-4EF6-A4BF-E3F364FDE989
P2860
Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Preclinical evaluation of telo ...... bone and soft tissue sarcomas.
@en
Preclinical evaluation of telo ...... bone and soft tissue sarcomas.
@nl
type
label
Preclinical evaluation of telo ...... bone and soft tissue sarcomas.
@en
Preclinical evaluation of telo ...... bone and soft tissue sarcomas.
@nl
prefLabel
Preclinical evaluation of telo ...... bone and soft tissue sarcomas.
@en
Preclinical evaluation of telo ...... bone and soft tissue sarcomas.
@nl
P2093
P1476
Preclinical evaluation of telo ...... bone and soft tissue sarcomas
@en
P2093
Aki Yoshida
Futoshi Uno
Ryosuke Yoshida
Shuya Yano
Toshifumi Ozaki
Toshiyoshi Fujiwara
Toshiyuki Kunisada
Tsuyoshi Sasaki
Yasuo Urata
P304
P356
10.1158/1078-0432.CCR-10-2066
P407
P577
2011-02-16T00:00:00Z